The HBB gene provides instructions for making part of hemoglobin, the protein in red blood cells that carries oxygen around your body. This gene plays an important role in keeping red blood cells flexible and working well as they travel through small blood vessels. When HBB does not work properly, hemoglobin can be reduced or abnormal, which can lead to conditions such as beta thalassemia or sickle cell disease with anemia, fatigue, and pain episodes. Some people carry one changed copy (sickle cell trait) and usually have few or no symptoms but can pass the change to children.
What is a gene?
Genes are pieces of DNA that carry instructions your cells use to make molecules or to manage activities in the body. Some genes provide the directions for producing proteins, which act as the cell’s main working components. Other genes are more focused on regulating when a process happens, where it takes place, and how strongly it is carried out. In combination, genes affect how your body grows and works, and they can also shape how you react to things like food, stress, or medications. For a deeper look at this subject, you can read more in the LearnHub.
Overview
HBBGene function
What if the gene works
The HBB gene provides instructions for the beta part of hemoglobin, the protein in red blood cells that carries oxygen. Normal HBB function supports healthy red blood cell performance and oxygen delivery throughout the body.
Risk
What if the gene does not work
Changes in the HBB gene can reduce oxygen carrying in blood cells, causing anemia with tiredness and jaundice. DNA changes range from mild trait to severe sickle cell disease or β-thalassemia, influencing when symptoms begin and how severe they become.
Treatment
What does that mean for your treatment
Variants in the HBB gene can influence choices like transfusion schedules, chelation, and eligibility for gene therapies. Raising fetal hemoglobin from the HBG1/HBG2 genes can partly compensate, so treatments such as hydroxyurea or gene editing may focus on boosting it.
Conditions associated with HBB
Gene function
What if the gene works
Every time you climb stairs or carry groceries, your muscles need a steady oxygen supply. Your cells rely on the HBB gene to make part of hemoglobin, the main oxygen-carrying protein in red blood cells. In most adults, this hemoglobin form does the bulk of day-to-day oxygen delivery. It also supports normal blood chemistry as gases move in and out of the bloodstream.
The HBB gene provides instructions for the hemoglobin beta chain, a key piece of adult hemoglobin. This protein helps red blood cells pick up oxygen in the lungs and release it to tissues throughout the body.
Hemoglobin made with help from the HBB gene is packed into red blood cells in very high amounts. This lets each cell carry a large oxygen load while staying flexible enough to travel through tiny blood vessels.
Hemoglobin also helps manage gases besides oxygen as blood circulates. It can carry a portion of carbon dioxide and helps buffer acids (so blood pH stays in a healthy range).
What is a variant?
A genetic variant is a minor difference in the DNA code within a gene. These differences are widespread and help explain normal variation among people, including traits like appearance, metabolism, or the way the body reacts to environmental factors. A large number of variants do not cause any obvious change and are part of typical genetic diversity. In certain situations, though, a variant can affect how a gene works more significantly and may play a role in, or lead to, a genetic condition.
Genetic variants
What if the gene does not work
Changes in the HBB gene can make hemoglobin less able to carry oxygen smoothly, which can shorten red blood cell survival. A single-letter HBB gene mutation may create hemoglobin S or hemoglobin C, while other variants lower or eliminate beta-globin production (beta thalassemia). Variants range from milder changes that still allow some beta-globin to be made to severe mutations that make little or none, which can influence when symptoms start, how strong anemia is, and which complications appear.
How variants are linked to conditions
Certain inherited changes in the HBB gene can cause blood conditions that affect how red blood cells carry oxygen. Well-established examples include HBB gene variants linked to sickle cell disease, as well as sickle cell trait in carriers. Other pathogenic variants can cause β-thalassemia (including major, intermedia, and trait), leading to anemia that ranges from mild to severe. Some variants also cause hemoglobin C or hemoglobin E conditions, sometimes combined with thalassemia.
A variant is not necessarily a diagnosis
Differences in DNA are expected in humans and are widespread across the population. The majority of genetic variants do not directly change a person’s health and instead represent normal human variation. With many genes, having a variant that has been linked to a condition points to a potential connection, not a certain diagnosis, particularly when several genes and environmental influences also play a role. In other situations, though, one clearly established variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For HBB gene conditions like sickle cell disease or beta thalassemia, whether you have the condition is mostly set by the gene change you were born with, and lifestyle cannot “undo” it. Even so, problems can be triggered or worsened by dehydration, low oxygen (such as high altitude), smoking, and untreated infections. Staying well hydrated, avoiding low-oxygen situations, and keeping up with vaccines and prompt infection care can help prevent complications.
Inheritance of HBB variants
Changes in the HBB gene are usually inherited in an autosomal recessive pattern, which means you typically need two nonworking copies to have a hemoglobin condition such as sickle cell disease or beta thalassemia. If both parents carry one HBB gene change, each pregnancy has a 25% chance of an affected child, a 50% chance of a carrier, and a 25% chance of neither. This explains how HBB gene variants are inherited in families of any sex.
What does my HBB result mean for my family?
Talk with a clinician or genetic counselor if your HBB result shows a change linked to sickle cell disease or beta thalassemia, since close relatives may also be carriers or affected. Seek medical advice sooner if you or your child has ongoing tiredness, pale skin, shortness of breath, frequent infections, yellowing of the eyes, or episodes of severe pain. Your result can also guide treatment choices such as transfusions, certain medicines, and pregnancy care.
Genetic information
Genetic testing
How you find out about variants
An HBB genetic test for sickle cell trait and beta thalassemia can clarify whether you carry a gene change linked to these inherited blood conditions, using a blood draw or saliva sample. A lab reads the HBB gene code with targeted testing or sequencing and reports a variant as benign, uncertain, or pathogenic, which can confirm carrier status or help explain certain anemia patterns.
When should I consider getting a genetic test?
Consider HBB genetic testing if you or a close family member has sickle cell disease or thalassemia (blood conditions that affect hemoglobin), or if you have long-lasting anemia that isn’t explained by iron levels. Testing is also useful when planning a pregnancy, especially if your partner has a family history or is known to be a carrier. Newborn screening may already check for these conditions.
A genetic result is only one part of your health story
Genetic results can be very informative, yet what they mean in practice varies based on the specific condition and the kind of variant found. Your health over time is also shaped by factors like lifestyle, environment, age, and your medical history. With some conditions, particularly those affected by many genes, genetic findings provide helpful background information but do not give a definite prediction and make the most sense when considered with the rest of your care. In other situations, the result may offer a straightforward explanation. When it comes to how you respond to medications, genetic information can also help put your personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines, and differences in blood proteins can be one part of that picture. Changes in the HBB gene can lead to hemoglobin conditions such as sickle cell disease or beta thalassemia, and these conditions can influence how your body tolerates treatments, how side effects show up, and what lab results mean during therapy. More broadly, genes can shape how quickly a drug is processed, how strongly it acts in the body, or how sensitive you are to unwanted effects, so the same medication can feel very different from one person to the next. Genetic information is one factor clinicians can consider alongside age, other health conditions, and other medicines when choosing and monitoring treatment.
What is Pharmacogenetics?
Pharmacogenetics focuses on how inherited genetic differences can affect the way medications work in different people. It examines relationships between specific genes and particular drugs to explain why the same treatment may not have the same effect for everyone. With many medicines, genetics can influence both how your body handles a drug and how strong its effects are. Understanding this can support more informed choices and a more individualized approach to treatment. More information on this topic is available in the LearnHub.
Drugs influenced by the HBB gene
When should I seek medical advice?
Seek medical advice if you or your child has ongoing tiredness, pale skin, yellowing of the eyes, frequent infections, shortness of breath, or episodes of severe bone or chest pain, since some changes in the HBB gene can cause conditions like sickle cell disease or thalassemia. Get urgent care for breathing trouble, fever, chest pain, or signs of stroke. Tell your clinician about any known HBB change before blood transfusions or starting new long-term medicines.
History
Inherited patterns of anemia and pain crises were recognized long before the HBB gene was identified. In 1949, researchers showed that sickle cell disease comes from an altered form of hemoglobin, a finding often described as the start of “molecular medicine.” Building on this early work, scientists later traced the change to a single amino acid difference and connected it to a specific change in the DNA of the HBB gene. In the 1970s and 1980s, advances in DNA testing made it possible to identify HBB gene variants directly, which supported carrier screening and prenatal diagnosis in some families. The gene became a central model for understanding conditions like sickle cell disease and beta thalassemia, helping genetics move from observation to precise laboratory testing. Over time, this work also shaped public health programs in regions where these inherited blood conditions are more common.